Soros Fund Management’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-384,096
Closed -$32.7M 180
2020
Q3
$32.7M Buy
+384,096
New +$19.4M 0.8% 25

Soros Fund Management's IMMU Position: Q4 2020 in Review

Soros Fund Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 384,096 shares — an estimated $32.7M sold.

Soros Fund Management first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $32.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Soros Fund Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Soros Fund Management sold 384,096 Immunomedics Inc shares in Q4 2020, an estimated $32.7M.
  • Soros Fund Management first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
  • Soros Fund Management's Immunomedics Inc position peaked at $32.7M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Soros Fund Management's 13F filing for Q4 2020, filed 16 Feb 2021.